Zsófia Sztupinszki

1.9k citations

34 papers · 691 indexed · h-index 15

Co-authors: Zoltán Szállási Miklós Dióssy Balázs Győrffy István Csabai Aron C. Eklund Marcin Krzystanek Nicolai J. Birkbak Lilla Reiniger
Topics: DNA Repair Mechanisms (9 papers)Cancer Genomics and Diagnostics (9 papers)PARP inhibition in cancer therapy (9 papers)
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: The Journal of Cell Biology PLoS ONE Cancer Research
Partner nations: Denmark Hungary United States

In The Last Decade

Zsófia Sztupinszki

34 papers receiving 687 citations

Peers

Countries citing papers authored by Zsófia Sztupinszki

Since Specialization

Citations

This map shows the geographic impact of Zsófia Sztupinszki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zsófia Sztupinszki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zsófia Sztupinszki more than expected).

Fields of papers citing papers by Zsófia Sztupinszki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zsófia Sztupinszki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zsófia Sztupinszki. The network helps show where Zsófia Sztupinszki may publish in the future.

Co-authorship network of co-authors of Zsófia Sztupinszki

This figure shows the co-authorship network connecting the top 25 collaborators of Zsófia Sztupinszki. A scholar is included among the top collaborators of Zsófia Sztupinszki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zsófia Sztupinszki. Zsófia Sztupinszki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histopathology and proteomics are synergistic for high-grade serous ovarian cancer platinum response prediction 2025 ·npj Precision Oncology ·(unknown),(unknown),(unknown),Lilla Madaras,Péter Pollner,Zoltán Szállási,Zsófia Sztupinszki,István Csabai	2
2	Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis 2023 ·Oncogene ·(unknown),(unknown),(unknown),Jinrong Huang,(unknown),(unknown),(unknown),Zsófia Sztupinszki,Robert Strauss,Mesut Bilgin,Kenji Maeda,Bin Liu,Yonglun Luo,Marja Jäättelä,Tuula Kallunki	11
3	Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors 2023 ·iScience ·Pranshu Sahgal,Deepa T. Patil,(unknown),Zsófia Sztupinszki,Viktória Tisza,Sándor Spisák,(unknown),Brandon M. Huffman,(unknown),Harshabad Singh,Jean‐Bernard Lazaro,Zoltán Szállási,James M. Cleary,Nilay S. Sethi	5
4	Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown),Zsófia Sztupinszki,Inge Marie Svane,Zoltán Szállási,Göran Jönsson,Marco Donia	8
5	Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy 2022 ·Cancer Immunology Research ·Morten Nielsen,(unknown),Zsófia Sztupinszki,(unknown),Arianna Draghi,Christopher A. Chamberlain,(unknown),Christina W. Yde,John Wojcik,Zoltán Szállási,Michael D. Crowther,Inge Marie Svane,Marco Donia	9
6	RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer 2022 ·Science Advances ·Chenkui Miao,Takuya Tsujino,Tomoaki Takai,Fu Gui,Takeshi Tsutsumi,Zsófia Sztupinszki,Zengjun Wang,Haruhito Azuma,Zoltán Szállási,Kent W. Mouw,Lee Zou,Adam S. Kibel,Jia Li	25
7	Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer 2021 ·Clinical Cancer Research ·(unknown),Miklós Dióssy,Zsófia Sztupinszki,(unknown),Viktória Tisza,Sándor Spisák,Orsolya Rusz,(unknown),Helle Pappot,István Csabai,Søren Brunak,Kent W. Mouw,Zoltán Szállási	18
8	Comparative Assessment of Diagnostic Homologous Recombination Deficiency–Associated Mutational Signatures in Ovarian Cancer 2021 ·Clinical Cancer Research ·Zsófia Sztupinszki,Miklós Dióssy,(unknown),(unknown),Nanna Cornelius,(unknown),Mansoor Raza Mirza,Zoltán Szállási	20
9	Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification 2021 ·Clinical Cancer Research ·(unknown),Zsófia Sztupinszki,(unknown),Inna M. Chen,Astrid Z. Johansen,Benny Vittrup Jensen,Stig E. Bojesen,Dorte Nielsen,Carsten Palnæs Hansen,Jane P. Hasselby,Kaspar René Nielsen,Zoltán Szállási,Julia S. Johansen	22
10	Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers 2021 ·Cancer Research ·Jintao Guo,Ying Zhou,Chaoqun Xu,Qinwei Chen,Zsófia Sztupinszki,(unknown),(unknown),Feng Ye,Weiwei Tang,(unknown),Lu Yang,(unknown),(unknown),Tianhui Hu,Rongshan Yu,Zoltán Szállási,Xianming Deng,Qiyuan Li	6
11	A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures 2021 ·npj Precision Oncology ·Miklós Dióssy,Zsófia Sztupinszki,(unknown),Marek Krzystanek,Viktória Tisza,Sándor Spisák,Orsolya Rusz,József Tı́már,István Csabai,János Fillinger,Judit Moldvay,Anders Gorm Pedersen,Dávid Szüts,Zoltán Szállási	19
12	Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations 2020 ·Clinical Cancer Research ·Zsófia Sztupinszki,Miklós Dióssy,Marek Krzystanek,(unknown),Mark M. Pomerantz,Viktória Tisza,Sándor Spisák,Orsolya Rusz,István Csabai,Matthew L. Freedman,Zoltán Szállási	56
13	Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors 2018 ·Annals of Oncology ·Miklós Dióssy,Lilla Reiniger,Zsófia Sztupinszki,Marcin Krzystanek,Kirsten M. Timms,Christopher Neff,(unknown),Dmitry Pruss,Aron C. Eklund,Erika Tóth,Orsolya Kiss,Orsolya Rusz,Gábor Cserni,Tamás Zombori,Borbála Székely,Janina Kulka,József Tı́már,István Csabai,Zoltán Szállási	53
14	Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer 2018 ·npj Breast Cancer ·Zsófia Sztupinszki,Miklós Dióssy,Marcin Krzystanek,Lilla Reiniger,István Csabai,Francesco Favero,Nicolai J. Birkbak,Aron C. Eklund,Ali Syed,Zoltán Szállási	152
15	Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers 2018 ·Annals of Oncology ·Nicolai J. Birkbak,Y. Li,Shailja Pathania,April Greene-Colozzi,Matija Dreze,Christian Bowman-Colin,Zsófia Sztupinszki,Marcin Krzystanek,Miklós Dióssy,Nadine Tung,Paula D. Ryan,Judy E. Garber,Daniel P. Silver,J. Dirk Iglehart,Zhicheng Wang,Dávid Szüts,Zoltán Szállási,Andrea L. Richardson	47
16	Validation of RNAi Silencing Efficiency Using Gene Array Data shows 18.5% Failure Rate across 429 Independent Experiments 2016 ·Molecular Therapy — Nucleic Acids ·Gyöngyi Munkácsy,Zsófia Sztupinszki,Peter G. Herman,(unknown),(unknown),(unknown),Balázs Győrffy	9
17	Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models 2016 ·Scientific Reports ·Zsófia Sztupinszki,Balázs Győrffy	20
18	Identifying Resistance Mechanisms against Five Tyrosine Kinase Inhibitors Targeting the ERBB/RAS Pathway in 45 Cancer Cell Lines 2013 ·PLoS ONE ·(unknown),(unknown),Attila Marcell Szász,Zsófia Sztupinszki,István Likó,Attila Szendrői,Reinhold Schäfer,Balázs Győrffy	19
19	High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy 2013 ·Thrombosis Research ·(unknown),(unknown),István Hizoh,(unknown),(unknown),Zsófia Sztupinszki,(unknown),Andrea Kovács,István Préda,Emese Tóth-Zsámboki,Róbert Gábor Kiss	8
20	The CIN4 Chromosomal Instability qPCR Classifier Defines Tumor Aneuploidy and Stratifies Outcome in Grade 2 Breast Cancer 2013 ·PLoS ONE ·Attila Marcell Szász,Qiyuan Li,Aron C. Eklund,Zsófia Sztupinszki,Andrew Rowan,Anna‐Mária Tõkés,Borbála Székely,András Kiss,Miklós Szendrői,Balázs Győrffy,Zoltán Szállási,Charles Swanton,Janina Kulka	25

About Zsófia Sztupinszki

Zsófia Sztupinszki is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 34 papers that have together received 691 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (9 papers), Cancer Genomics and Diagnostics (9 papers) and PARP inhibition in cancer therapy (9 papers). The work is most often cited by research in Cancer Research (234 citations), Oncology (398 citations) and Pulmonary and Respiratory Medicine (199 citations). Zsófia Sztupinszki has collaborated with scholars based in Denmark, Hungary and United States. Frequent co-authors include Zoltán Szállási, Miklós Dióssy, Balázs Győrffy, István Csabai, Aron C. Eklund, Marcin Krzystanek, Nicolai J. Birkbak, Lilla Reiniger, Ali Syed and Francesco Favero. Their work appears in journals such as The Journal of Cell Biology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact